SCHEMBL6900684

SCHEMBL6900684

c1ccc(-c2cccc3ccccc23)c(Oc2ccccc2-c2cccc3ccccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 3/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTR1B P28222 3/20 0.42
MEN1 O00255 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP2A6 P11509 3/20 0.42
HSD17B10 Q99714 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
TSHR P16473 2/20 0.42
CNR2 P34972 1/20 0.41
HPGD P15428 2/20 0.40
PTPN1 P18031 1/20 0.40
KCNA3 P22001 1/20 0.40
ALPL P05186 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10540676 0.91 ALDH1A1 (0.51) ALDH1A1KDM4EGAAMAPTNPSR1
SCHEMBL3598954 0.83 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTNPSR1L3MBTL1
SCHEMBL25302086 0.83 ALDH1A1 (0.59) ALDH1A1KDM4EGAAMAPTL3MBTL1
SCHEMBL27953 0.83 ALDH1A1 (0.59) ALDH1A1KDM4EGAAMAPTL3MBTL1
SCHEMBL29350007 0.83 ALDH1A1 (0.59) ALDH1A1KDM4EGAAMAPTL3MBTL1
SCHEMBL1178230 0.82 NCOA1 (0.60) ALDH1A1GAAMAPTL3MBTL1HTR1B
SCHEMBL28412513 0.81 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTNPSR1L3MBTL1
SCHEMBL10931211 0.80 SIRT2 (0.42) ALDH1A1KDM4EGAAMAPTNPSR1
SCHEMBL29577853 0.80 HTR1B (0.54) ALDH1A1KDM4EGAAMAPTNPSR1
SCHEMBL442767 0.80 HTR1B (0.54) ALDH1A1KDM4EGAAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116354891-B Naphthyl phenyl ether compound, and preparation method and application thereof 河南省锐达医药科技有限公司 2025-01-07 CN claimed
CN-116829527-A Naphthyl phenyl ether compound and lubricating oil composition containing the same 株式会社MORESCO 2023-09-29 CN claimed
CN-116354891-A Naphthyl phenyl ether compound, and preparation method and application thereof 河南省锐达医药科技有限公司 2023-06-30 CN claimed
WO-2022172934-A1 NAPHTHYL PHENYL ETHER COMPOUND AND LUBRICANT COMPOSITION CONTAINING SAME 株式会社MORESCO 2022-08-18 WO claimed
EP-4596645-A1 COATING COMPOSITION FOR ENDOSCOPES, LUBRICATION MEMBER FOR ENDOSCOPES, METHOD FOR PRODUCING LUBRICATION MEMBER FOR ENDOSCOPES, FLEXIBLE TUBE FOR ENDOSCOPES, AND ENDOSCOPE FUJIFILM Corporation (JP) 2025-08-06 EP disclosed
CN-116829527-B Naphthyl phenyl ether compound and lubricating oil composition containing the same 株式会社MORESCO 2025-08-01 CN disclosed
US-20250205395-A1 COATING COMPOSITION FOR ENDOSCOPE, LUBRICATING MEMBER FOR ENDOSCOPE, METHOD FOR MANUFACTURING LUBRICATING MEMBER FOR ENDOSCOPE, FLEXIBLE TUBE FOR ENDOSCOPE, AND ENDOSCOPE FUJIFILM CORPORATION (JP) 2025-06-26 US disclosed
CN-118891302-A Epoxy resin, cured product of epoxy resin, and method for producing epoxy resin 积水化学工业株式会社 2024-11-01 CN disclosed
WO-2024071044-A1 COATING COMPOSITION FOR ENDOSCOPES, LUBRICATION MEMBER FOR ENDOSCOPES, METHOD FOR PRODUCING LUBRICATION MEMBER FOR ENDOSCOPES, FLEXIBLE TUBE FOR ENDOSCOPES, AND ENDOSCOPE 富士フイルム株式会社 2024-04-04 WO disclosed
CN-116829527-A Naphthyl phenyl ether compound and lubricating oil composition containing the same 株式会社MORESCO 2023-09-29 CN disclosed
CN-116829527-A Naphthyl phenyl ether compound and lubricating oil composition containing the same 株式会社MORESCO 2023-09-29 CN disclosed
WO-2023182522-A1 EPOXY RESIN, CURED BODY OF SAME AND METHOD FOR PRODUCING EPOXY RESIN 積水化学工業株式会社 2023-09-28 WO disclosed
US-20150105351-A1 COMPOUNDS AND METHODS FOR TREATING HIV INFECTIONS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-04-16 US disclosed
CN-104364226-A Catalytic dehydration of aryl alcohols to diaryl ethers DOW GLOBAL TECHNOLOGIES INC 2015-02-18 CN disclosed
CN-104271544-A Catalytic dehydration of aryl alcohols to diaryl ethers DOW GLOBAL TECHNOLOGIES INC 2015-01-07 CN disclosed
EP-0939070-B1 Process for the preparation of six-ring carbocyclic compounds BAYER MATERIALSCIENCE AG (DE) 2004-06-23 EP disclosed
WO-2001090037-A1 METHOD FOR PRODUCING ACYLATED PHENOL ETHERS BAYER AKTIENGESELLSCHAFT (DE) 2001-11-29 WO disclosed
US-6043247-A A SUBSTITUTED ACRYLIC ACIDS FOR USE IN TREATMENT OF HUMAN AND ANIMAL DISORDERS, AND PURIFICATION OF PROTEINS OR GLYCOPROTEINS, AND TO THEIR USE IN DIAGNOSIS NOVO NORDISK A/S (DK) 2000-03-28 US disclosed
EP-0939070-A1 Process for the preparation of six-ring carbocyclic compounds Bayer Aktiengesellschaft (DE) 1999-09-01 EP disclosed
WO-1997039748-A1 MODULATORS OF MOLECULES WITH PHOSPHOTYROSINE RECOGNITION UNITS NOVO NORDISK A/S (DK) 1997-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105351-A1 COMPOUNDS AND METHODS FOR TREATING HIV INFECTIONS POLM, POLRMT, DHFR ALDH1A1 1200/4885KDM4E 2839/4885GAA 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.